March 2013: East West Capital Partners led a multi-million dollar Series A funding round joined by US-based investment firms GRI Fund, ASAP Ventures and prominent Angel Investors in cell therapy company, Seraxis Pte Ltd.
Seraxis uses proprietary cell culture technology to develop cell therapies to treat insulin-dependent diabetes, and has commenced operations. This start-up is headquartered in Singapore with a subsidiary, Seraxis Inc., in Germantown, Maryland USA. The company also has support from the foundation Dads Against Diabetes (DAD).
Sanjay Sehgal, Managing Partner & CEO of EWCP has been elected to the Board of Seraxis.
The US Subsidiary is a new tenant of the Germantown Innovation Center, a business incubator program of the Montgomery County, Department of Economic Development Business Innovation Network.
For more information and contact, please visit www.seraxis.com